Ken Uchino, MD
Cleveland Clinic Main Campus
Chagrin Falls Family Health Center
551 E Washington Street
Chagrin Falls, OH 44022
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, OH 44195
Treatment & Services
- Cerebrovascular Neurology
- Clinical Evaluation, Diagnosis And Treatment
- Lumbar Puncture (Spinal Tap)
- Neurovascular Ultrasound
- Stroke Epidemiology
Specialty in Diseases & Conditions
- Acute Ischemic Stroke
- Acute Stroke
- Atherosclerosis (vascular)
- Basilar Artery Disease
- Brain Hemorrhage
- Carotid Artery Disease
- Central Nervous System Vasculitis
- Cerebral Amyloid Angiopathy
- Cerebral Vasculitis
- Cerebrovascular Disease
- Cerebrovascular Occlusive Disease
- Hemorrhagic Stroke
- Intracranial Atherosclerosis
- Intracranial Hemorrhage, Cerebral Hemorrhage, & Hemorrhagic Stroke
- Intracranial Stenosis
- Moya Moya Disease
- Patent Foramen Ovale
- Secondary Stroke Prevention
- Transient Ischemic Attack (TIA)
- Vertebral Artery Disease
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.View All Plans
About Ken Uchino, MD
Ken Uchino, MD, is a stroke neurologist at Cerebrovascular Center at Neurological Institute at Cleveland Clinic. He is the Director of Research and Education at Cerebrovascular Center and is the program director of Vascular Neurology Fellowship. He is a Professor of Medicine (Neurology), Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr Uchino’s interest cover a range from acute stroke treatment and causes of strokes and prevention and sees patients in hospital with acute stroke and in outpatient clinic.
He graduated from New York University School of Medicine, and trained in neurology at University of Washington, Seattle. He completed a two-year fellowship in cerebrovascular diseases at University of Texas-Houston. He was on the faculty at University of Pittsburgh for 6 years and since 2009 has been a staff physician at Cleveland Clinic Cerebrovascular Center.
Dr Uchino has published over 130 peer-reviewed papers. He has research interests in particular in acute stroke treatment and intracranial stenosis (narrowing of brain arteries).
Education & Professional Highlights
Education & Fellowships
Fellowship - University of Texas Affiliated Hospitals
Houston, TX USA
Residency - University of Washington Medical Center
Seattle, WA USA
Internship - University of Washington Medical Center
Seattle, WA USA
Medical Education - New York University School of Medicine
New York, NY USA
Undergraduate - Harvard University
Cambridge, MA USA
- Psychiatry and Neurology - Neurology
- Psychiatry and Neurology - Vascular Neurology
acute stroke treatment, carotid artery disease, carotid artery stenosis, cerebrovascular disease, cerebrovascular neurology, hemorrhagic stroke, intracranial stenosis, ischemic stroke, neurovascular ultrasound, secondary stroke prevention, stroke, stroke epidemiology and risk factor modification, stroke outcomes, vasculitis
Research & Publications
See publications for Ken Uchino, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/17/2022, Dr. Uchino has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.